Moxifloxacin

• Oral Antibiotic Outpatient Therapy vs. Placebo in the Treatment of Uncomplicated Acute Appendicitis Pending
  2023-506213-21-00 Phase IV 1 country Turku University Hospital
• Feasibility of the Application of a new Six-month Treatment for multidrug-resistant tuberculosis (MDR-TB) patients in France (FAST-MDR) Pending
  2024-512763-32-00 Phase III 1 country Assistance Publique Hopitaux De Paris
• Optimizing the antibiotic treatment of uncomplicated acute appendicitis - APPAC II Pending
  2024-518984-36-00 Phase IV 1 country Turku University Hospital
• Acute appendicitis and microbiota – etiology and effects of the antimicrobial treatment - MAPPAC Pending
  2024-519392-26-00 Phase IV 1 country Turku University Hospital
• Efficacy and safety of Dalbavancin in the treatment of infective Endocarditis caused by gram-positive cocci Pending
  2026-526149-91-00 Phase III 1 country Friedrich-Schiller-Universitaet Jena
• Rapid Oral Switch in Infectious Endocarditis, the ROSIE study Recruiting
  2025-524484-20-00 Phase IV 1 country UZ Leuven
• A Multicentric Randomized Double-Blind Phase 3 Trial Evaluating the Efficacy of an Adapted Antibiotherapy in Hurley Stage 2 Active Hidradeni… Recruiting
  2023-505818-16-00 Phase III 1 country Institut Pasteur
• Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia: A randomized, non-blinded, no… Recruiting
  2024-519186-21-01 Phase IV 1 country Hvidovre Hospital
• Ampicillin and ceftriaxone for the treatment of Enterococcus faecalis infective endocarditis. Recruiting
  2024-511719-40-00 Phase IV 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
• Efficacy and safety of different antimicrobial DURATions for the treatment of Infections associated with Osteosynthesis Material implanted a… Recruiting
  2023-508442-18-00 Phase III 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
• SAVE- oral antibiotics for treatment of vertebral osteomyelitis Recruiting
  2023-507617-96-01 Phase IV 1 country Rigshospitalet
• Impact of rifampicin in treatment outcome of Cutibacterium spp. prosthetic joint infections - RIFACute Recruiting
  2022-502974-18-00 Phase II/III 1 country Centre Hospitalier Universitaire De Nice
• Staphylococcus aureus Network Adaptive Platform trial (SNAP) Recruiting
  2023-503582-35-00 Phase IV 4 countries University Medical Center Utrecht
• A Study of Aztreonam-Avibactam (ATM-AVI) Compared to Best Available Therapy in Pediatric Participants with Serious Gram-Negative Bacterial C… Recruiting
  2022-501575-12-00 Phase II 4 countries Pfizer Inc.
• Finding the best treatment for lung disease from infection with Mycobacterium abscessus Recruiting
  2023-506575-99-00 Phase II 1 country The University Of Queensland
• Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia (REMAP-CAP) Ended
  2023-507889-89-00 Phase III 13 countries Universitair Medisch Centrum Utrecht
• A Four Way Crossover Thorough QT/QTc Study to Evaluate the Electrocardiographic Effects of Therapeutic and Supratherapeutic Doses of Cytisin… Ended
  2022-500954-40-00 Phase I (Other) 1 country Achieve Life Sciences Inc.

Showing 1–17 of 17 trials